Weight Loss: Tirzepatide (same ingredient in Mounjaro & Zepbound)
$299.00
Continue your weight loss journey with the Tirzepatide—featuring the same active ingredient as Mounjaro & Zepbound for sustained results.
WHAT IS IT:
This medication is self-administered by the patient once weekly via a subcutaneous injection. Tirzepatide is a dual GIP and GLP-1 receptor agonist (natural hormones in your body) that helps support weight loss and blood sugar control. It works by enhancing insulin sensitivity, slowing digestion, and reducing appetite—leading to improved metabolic function and sustained satiety. All of our formulations of tirzepatide also include pyridoxine (Vitamin B6). The addition of Vitamin B6 has clinical evidence that supports decreasing nausea and helps aid with weight loss.
PROCESS:
Schedule an appointment.
$49 telehealth call with MD or NP to ensure treatment is safe, appropriate, & tailored to your needs ($49 not included in listed service price above, but is only required once every 6 months for weight loss treatments so you won’t need to pay it again when it’s time to refill your prescription).
Telehealth call with RN (no extra charge) to discuss supplies provided & appropriate dosage. During call, patient will be instructed on how to administer the medication. If needed, patient can schedule for the RN to demonstrate the 1st dose in person.
Prescription & supplies shipped to patient.
Patient self-administers medications per prescription & educational guidelines.
We’re always available via call/text/email if you have any questions or concerns.
In summary, we offer a concierge service that includes everything you need: medical oversight, prescription medication, needed supplies, access to experienced critical care RNs that can help with your titration schedule and answer any questions that may arise.
TIRZEPATIDE DOSING*
● Initial Dose:
○ 2.25 mg Subcutaneous (SC) once weekly for 4 weeks. $299 (4 shots)
● Titration Schedule (Only If Needed):
○ Week 5-8: 4.5 mg SC once weekly for 4 weeks. $349 (4 shots)
○ Week 9–12: 6.75 mg SC once weekly for 4 weeks. $449 (4 shots)
○ Week 13–16: 9 mg SC once weekly for 4 weeks. $529 (4 shots)
○ Week 17+: 11.5 mg SC once weekly for 4 weeks. $619 (4 shots)
● Maximum Dose: 13.5 mg SC once weekly for 4 weeks. $619 (4 shots)
*Dosing increase is not a requirement for efficacy; increase dosage only if your appetite suppression has diminished. We suggest that clients remain on their current dosage as long as they’re experiencing effective appetite control. If the effects begin to diminish, it may be time to increase the dose. For example, if 2.25mg is no longer providing adequate results, consider moving up to 4.5mg. The same approach applies when transitioning from 4.5mg to 6.75mg, from 6.75mg to 9mg, and from 9mg to 11.5 or 13.5mg.
PHARMACY INFO:
All of our sterile compounded items are sterility and potency tested prior to leaving the pharmacy.
Our average potency on both semaglutide and tirzepatide ranges from 99%-105%; we do not dispense any product that fails to meet this potency criteria.
We only use FDA certified AND MORE IMPORTANTLY, FDA INSPECTED, suppliers.
We only use Semaglutide Base and Tirzepatide Base, we DO NOT use any salt forms which have been flooding the market due to the significantly lower cost. These products ARE NOT THE SAME as the true base forms that we use.
NOTICE: BMI ≥ 27 required to qualify for Tirzepatide treatment at our Practice.
The trademarked medications Saxenda®, Victoza®, Wegovy®, and Ozempic® are exclusively distributed by Novo Nordisk™, while Mounjaro™ and Zepbound™ are products of Eli Lilly and Company™. Holistick IV is not affiliated with or endorsed by any of these brands or companies and does not distribute their products. Individuals seeking these medications should consult a licensed medical provider or pharmacist.
Holistick IV offers access to custom-compounded medications prepared by state-licensed 503(a) compounding pharmacies. These medications are formulated specifically for individual patients based on a licensed provider’s prescription. Although these pharmacies follow strict regulatory standards, compounded medications are not FDA-approved because they are tailored to meet specific patient needs and may differ in strength, dosage, and route of administration from commercially available drugs. All prescriptions are provided at the discretion of a licensed healthcare provider following a telehealth consultation and review of the patient’s medical history.